Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Transplantation: Methods and Outcomes, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Organ Transplantation Techniques and Outcomes, and Renal Transplantation Outcomes and Treatments.
Results from randomized trial of pirfenidone in patients with chronic rejection (STOP-CLAD study)
The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation
Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates
Contemporary trends in PGD incidence, outcomes, and therapies
Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease
Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT
Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients
Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation
The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia
Redefining Primary Graft Dysfunction after Lung Transplantation
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
Analysis of Culture-Dependent versus Culture-Independent Techniques for Identification of Bacteria in Clinically Obtained Bronchoalveolar Lavage Fluid
Genetic Variation in the Prostaglandin E2 Pathway Is Associated with Primary Graft Dysfunction
Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality After Lung Transplantation
Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Latent Class Analysis Identifies Distinct Phenotypes of Primary Graft Dysfunction After Lung Transplantation
Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation
Variation in <i>PTX3</i> Is Associated with Primary Graft Dysfunction after Lung Transplantation
Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation
285 A Panel of Lung Injury Biomarkers Enhances the Definition of Primary Graft Dysfunction (PGD) after Lung Transplantation for Early Clinical Studies